BioNexus Gene Lab Corp Cash And Cash Equivalents At Carrying Value

Quick Answer

BioNexus Gene Lab Corp reported Cash And Cash Equivalents At Carrying Value of $2.12 million for the year ending 2021.

  • BioNexus Gene Lab Corp showed a decrease of -23.8% in Cash And Cash Equivalents At Carrying Value from 2020 to 2021.
  • This data is from BioNexus Gene Lab Corp's annual report (Form 10-K), filed with the SEC on April 6, 2022.
  • XBRL data for this metric is available from 2018 to 2021 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2018 to 2021), BioNexus Gene Lab Corp's Cash And Cash Equivalents At Carrying Value has grown by 68.5%.
  • Historical annual values: Fiscal year 2021: $2.12 million | Fiscal year 2020: $2.79 million | Fiscal year 2019: $859.1 thousand | Fiscal year 2018: $1.26 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: